SIM
AUXL

SSI Investment Management’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

SSI Investment Management’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-33,289
Closed -$690K – 455
2013
Q4 		$690K Sell
33,289
-6,790
-17% -$128K 0.06% 284
2013
Q3 		$729K Buy
40,079
+16,789
+72% +$303K 0.07% 254
2013
Q2 		$387K Buy
+23,290
New +$372K 0.04% 336

Other funds holding AUXL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
TCP
TAMRO Capital Partners Alexandria, Virginia $369M AUM 1.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SSI Investment Management's AUXL Position: Q1 2014 in Review

SSI Investment Management sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2014, closing a stake of 33,289 shares — an estimated $690K sold.

SSI Investment Management first reported a position in AUXL in Q2 2013 and held it in 3 quarters. The position peaked at $729K in Q3 2013. 163 funds tracked by Wall St. Rank hold AUXL as of Q1 2014.

  • SSI Investment Management reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2014 after selling out during the quarter.
  • SSI Investment Management sold 33,289 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2014, an estimated $690K.
  • SSI Investment Management first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 3 quarters.
  • SSI Investment Management's AUXILIUM PHARAMCEUTICALS INC position peaked at $729K in Q3 2013.
  • 163 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2014.

Based on SSI Investment Management's 13F filing for Q1 2014, filed 9 May 2014.